AzTrials
AzTrials

Success of OperationNCT06803160

Comparative Study of Laparoscopic Combined Trans-vesical and Extravesical Versus Laparoscopic Extravesical Fistula Excision in Uterovesical Fistula Repair: A Retrospective Observational Study

An observational study of Success of Operation, run by Ain Shams University at 1 site in Egypt.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to compare between laparoscopic combined trans-vesical and extravesical versus laparoscopic extravesical fistula excision in uterovesical fistula repair. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Success of Operation
What is being tested?
Laparoscopic Extravesical Fistula Excision of Uterovesical Fistula and Laparoscopic Combined Fistula Excision of Uterovesical Fistula
Type of treatment
Surgery or procedure
How many people
20 participants
Where
1 siteEgypt
Study dates
30 Jan 2025to 28 Feb 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: * This is a retrospective study involving the retrieval and analysis of medical records of uterovesical patients who were managed at the Urology and Gynecology departments at Ain Shams University Hospitals. * Patient's records that were included in the study satisfied the following criteria: * The patient was diagnosed with uterovesical fistula. * The patient had laparoscopic surgery with either approach at the Urology and Gynecology departments at Ain Shams University Hospitals. * The fistulous track was confirmed and had been repaired.

Who may be able to join

  • Patients diagnosed with uterovesical fistula with history of uterine cesarean section or any urogenital surgery complaining of amenorrhea, cyclic hematuria, with or without urinary incontinence.

Who cannot join

  • • Pregnant females.
  • Patients who refuse to participate in the study.
  • Patients with concomitant pathology that could affect symptoms e.g., polycystic ovary disease, stress incontinence, bladder cancer or overactive bladder.
  • Patients with malignant fistula.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site
  • Ain Shams University

    Cairo, 11865

Other trials in Egypt

About this study

  • The aim of this study is to compare between laparoscopic combined trans-vesical and extravesical versus laparoscopic extravesical fistula excision in uterovesical fistula repair.
Being tested
Laparoscopic Extravesical Fistula Excision of Uterovesical Fistula, Laparoscopic Combined Fistula Excision of Uterovesical Fistula

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laparoscopic Extravesical Fistula Excision of Uterovesical FistulaProcedure or surgery

    • In extravesical approach, the posterior bladder wall and the anterior uterine wall around the fistula will be dissected. Scar tissue around the orifice of the fistula will be removed and trimmed. After suturing uterine and bladder wall, intervening omentum will be placed in-between.
  • Laparoscopic Combined Fistula Excision of Uterovesical FistulaProcedure or surgery

    • In the combined approach, bladder will be opened bivalved till the site of the fistula. Scar tissue around the orifice of the fistula will be removed and trimmed. Careful dissection around the bladder and uterus will be done to suture both walls and place an intervening omentum in-between.
Study groups in NCT06803160
Study groupRoleWhat they receive
Laparoscopic Combined Fistula Excision of Uterovesical FistulaPatinets who underwent Laparoscopic Combined Fistula Excision of Uterovesical Fistula
Receives: Procedure: Laparoscopic Extravesical Fistula Excision of Uterovesical Fistula; Procedure: Laparoscopic Combined Fistula Excision of Uterovesical Fistula

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. success of operation

    Success of operation with excision of fistula in upcoming CT cystogram

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2025
  2. Study start30 Jan 2025 (estimated)
  3. Primary completion28 Feb 2025 (estimated)
  4. Study completion28 Feb 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06803160
Sponsor's protocol ID
Lap Uterovesical Fistula
Status last verified
Jan 2025
First submitted
26 Jan 2025
Last updated
31 Jan 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Success of Operation, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 31 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

success of operation (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in